{"cdcTestId":"2013-0550","testcaseName":"Dose 1 MMRV at 12 m-4 days","vaccineGroup":"MMR","evaluationTestType":"Age: At Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2021-10-23T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PROQUAD","cvx":"94","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-23T00:00:00","recommendedDate":"2025-10-23T00:00:00","pastDueDate":"2028-11-19T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PROQUAD","cvx":"94","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-29T15:40:19.372","generalDescription":"This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 12 months -4 days, that the dose is considered to be valid.","changedInVersion":"1.0","reasonForChange":""}